Valuation: CTT Pharmaceutical Holdings, Inc.

Market Cap 3.88M 3.4M 3.17M 2.9M 5.46M 373M 5.54M 37.58M 14.68M 183M 14.55M 14.23M 634M P/E 2024
-11.9x
P/E 2025 -22.2x
Enterprise Value 3.88M 3.41M 3.17M 2.91M 5.46M 374M 5.55M 37.62M 14.7M 184M 14.56M 14.25M 635M EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
50.43%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer - -
Director TitleAgeSince
Director/Board Member 71 2014-09-08
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
-22.52%-0.09% - - 3.88M
+1.07%-3.49%-3.25%+12.87% 46.86B
+0.25%+1.65%+408.41%+629.49% 40.23B
-0.27%+4.45%+9.93%+66.92% 36.23B
+0.35%+0.87%+3.60%-8.81% 34.72B
+3.14%+1.02%+3.37%+38.15% 27.89B
-0.73%+11.84%+31.97%+143.53% 16.79B
+0.47%-2.74% - - 16.74B
+0.42%-5.52%+0.76%+8.50% 13.12B
-2.68%-2.49%-15.00%-31.68% 12.7B
Average -2.05%+0.83%+54.97%+107.37% 27.25B
Weighted average by Cap. +0.48%+0.91%+75.32%+136.64%

Financials

2024 2025
Net sales - -
Net income -250K -220K -204K -188K -352K -24.1M -358K -2.43M -948K -11.85M -939K -919K -40.96M -156K -137K -127K -117K -220K -15.01M -223K -1.51M -591K -7.38M -585K -573K -25.52M
Net Debt 16.82K 14.77K 13.74K 12.61K 23.69K 1.62M 24.05K 163K 63.73K 796K 63.14K 61.78K 2.75M 3.46K 3.03K 2.82K 2.59K 4.87K 333K 4.94K 33.51K 13.09K 164K 12.97K 12.69K 566K
Logo CTT Pharmaceutical Holdings, Inc.
CTT Pharmaceutical Holdings, Inc. specializes in drug delivery systems technology within the pharmaceutical industry. Its technology platform includes the development of advanced oral delivery thin wafers to deliver treatment as an alternate to smoking and ingestion. The wafer is an orally administrable paper-thin polymer film used as a carrier for pharmaceutical agents. It rapidly dissolves to release the pharmaceutical agent as soon as it comes in contact with saliva, thus obviating the need for water during administration. Its oral film technology drug delivery system can be provided in various packaging configurations, ranging from unit-dose pouches to multiple-dose blister packages. Its drug delivery system technology includes nicotine, vitamins, pharmaceuticals, and many other actives. It offers oral thin strips for pain management and inflammation indications, such as arthritis. VetWafe is used for pain management for pet markets. It is a thin film for treating dogs and cats.
Employees
-